DiaCarta and OncoAssure partner for prostate cancer test
OncoAssure’s Prostate prognostic test is a six-gene expression assay that detects the risk of aggressive disease and the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Feb 24
OncoAssure’s Prostate prognostic test is a six-gene expression assay that detects the risk of aggressive disease and the…
26 Feb 24
Research in prestigious journal places novel polyp detection system at highest level of performance in AI-aided colonoscopy category
22 Feb 24
Aptar Digital Health’s acquisition of Healint builds on an existing collaboration between the two companies, aimed at enhancing…
22 Feb 24
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
22 Feb 24
Both companies are dedicated to ensuring the successful deployment of this technology by providing training and support to…
21 Feb 24
The Smart Skin solution is a wireless wearable technology that comprises dry-printed multi-modal electrode patches to monitor brain…
21 Feb 24
By utilising EnsoSleep PPG scoring, pulse oximetry technology is expected to offer a high-quality, accessible, and cost-effective method…
20 Feb 24
The Aptiva APS IgG and APS IgM reagents are immunoassays designed for semi-quantitative determination of anti-cardiolipin (aCL) and…
20 Feb 24
The international research team, led by HKUST life science professor Nancy IP, developed an advanced blood test for…
16 Feb 24
The financing is expected to allow Freenome to advance the pipeline of single-cancer and customised multi-cancer early-detection tests